These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26367446)

  • 1. Expression of Nogo receptor 1 in microglia during development and following traumatic brain injury.
    Liu G; Ni J; Mao L; Yan M; Pang T; Liao H
    Brain Res; 2015 Nov; 1627():41-51. PubMed ID: 26367446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
    Israelsson C; Flygt J; Åstrand E; Kiwanuka O; Bengtsson H; Marklund N
    Restor Neurol Neurosci; 2014; 32(5):717-31. PubMed ID: 25079982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans.
    Dickendesher TL; Baldwin KT; Mironova YA; Koriyama Y; Raiker SJ; Askew KL; Wood A; Geoffroy CG; Zheng B; Liepmann CD; Katagiri Y; Benowitz LI; Geller HM; Giger RJ
    Nat Neurosci; 2012 Mar; 15(5):703-12. PubMed ID: 22406547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
    Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S
    Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nogo receptor 3, a paralog of Nogo-66 receptor 1 (NgR1), may function as a NgR1 co-receptor for Nogo-66.
    Zhang L; Kuang X; Zhang J
    J Genet Genomics; 2011 Nov; 38(11):515-23. PubMed ID: 22133682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice.
    Hånell A; Clausen F; Björk M; Jansson K; Philipson O; Nilsson LN; Hillered L; Weinreb PH; Lee D; McIntosh TK; Gimbel DA; Strittmatter SM; Marklund N
    J Neurotrauma; 2010 Jul; 27(7):1297-309. PubMed ID: 20486800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nogo receptor is involved in the adhesion of dendritic cells to myelin.
    McDonald CL; Steinbach K; Kern F; Schweigreiter R; Martin R; Bandtlow CE; Reindl M
    J Neuroinflammation; 2011 Sep; 8():113. PubMed ID: 21906273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Nogo-66 receptor 1 enhances recovery of cognitive function after traumatic brain injury in mice.
    Tong J; Liu W; Wang X; Han X; Hyrien O; Samadani U; Smith DH; Huang JH
    J Neurotrauma; 2013 Feb; 30(4):247-58. PubMed ID: 22967270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatio-temporal expression pattern of receptors for myelin-associated inhibitors in the developing rat olfactory system.
    Richard M; Sacquet J; Jourdan F; Pellier-Monnin V
    Brain Res; 2009 Feb; 1252():52-65. PubMed ID: 19063867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carboxyl-terminal region of Crtac1B/LOTUS acts as a functional domain in endogenous antagonism to Nogo receptor-1.
    Kurihara Y; Arie Y; Iketani M; Ito H; Nishiyama K; Sato Y; Nakamura F; Mizuki N; Goshima Y; Takei K
    Biochem Biophys Res Commun; 2012 Feb; 418(2):390-5. PubMed ID: 22281491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor.
    Kawakami Y; Kurihara Y; Saito Y; Fujita Y; Yamashita T; Takei K
    J Neurosci; 2018 Mar; 38(10):2589-2604. PubMed ID: 29440387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression patterns of messenger RNAs encoding Nogo receptors and their ligands in the rat central nervous system.
    Funahashi S; Hasegawa T; Nagano A; Sato K
    J Comp Neurol; 2008 Jan; 506(1):141-60. PubMed ID: 17990276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nogo receptor complex: confining molecules to molecular mechanisms.
    Schwab JM; Tuli SK; Failli V
    Trends Mol Med; 2006 Jul; 12(7):293-7. PubMed ID: 16723274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1.
    Saha N; Kolev MV; Semavina M; Himanen J; Nikolov DB
    Biochem Biophys Res Commun; 2011 Sep; 413(1):92-7. PubMed ID: 21872576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand.
    Kurihara Y; Iketani M; Ito H; Nishiyama K; Sakakibara Y; Goshima Y; Takei K
    Mol Cell Neurosci; 2014 Jul; 61():211-8. PubMed ID: 25034269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitis.
    Steinbach K; McDonald CL; Reindl M; Schweigreiter R; Bandtlow C; Martin R
    PLoS One; 2011; 6(11):e26341. PubMed ID: 22096481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members.
    Laurén J; Hu F; Chin J; Liao J; Airaksinen MS; Strittmatter SM
    J Biol Chem; 2007 Feb; 282(8):5715-25. PubMed ID: 17189258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
    Mi S; Lee X; Shao Z; Thill G; Ji B; Relton J; Levesque M; Allaire N; Perrin S; Sands B; Crowell T; Cate RL; McCoy JM; Pepinsky RB
    Nat Neurosci; 2004 Mar; 7(3):221-8. PubMed ID: 14966521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation.
    Sato Y; Iketani M; Kurihara Y; Yamaguchi M; Yamashita N; Nakamura F; Arie Y; Kawasaki T; Hirata T; Abe T; Kiyonari H; Strittmatter SM; Goshima Y; Takei K
    Science; 2011 Aug; 333(6043):769-73. PubMed ID: 21817055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha tocopherol treatment reduces the expression of Nogo-A and NgR in rat brain after traumatic brain injury.
    Yang J; Han Y; Ye W; Liu F; Zhuang K; Wu G
    J Surg Res; 2013 Jun; 182(2):e69-77. PubMed ID: 23207171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.